"Our hypothesis is that impacting the CD40L pathway, a central mechanism in immune response, would translate to significant impact on SLE disease burden," said Diana Gallagher, who is leading ...

1 Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan 2 Department of Functional Genomics and Immunological Diseases, Graduate School of Medicine ...

After being all-but written off a year ago, AstraZeneca’s anifrolumab has been reborn with new data that suggest it could help to end a drought in treatments for autoimmune disease systemic ...

Inheritance of Manasseh; Canaanites forced to pay taxes to Israelites; Tabernacle set up at Shiloh; remainder of the land divided. And the whole congregation of the children of Israel assembled ...

After hours: March 21 at 7:53:26 PM EDT Loading Chart for CMPS ...

Rituximab led to the most profound decrease in the activity of the B cell pathway, while cyclophosphamide uniquely downregulated neutrophil activation pathways. Responders, regardless of medication, ...